2021 Research Highlight
The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer Jeanny B Aragon-Ching Asian J Androl : 1-2; 10.4103/aja.aja_35_20 Full Text | PDF [704]
Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment Jialu Lv1, Jianqing Lin2 Asian J Androl : 229-230; 10.4103/aja.aja_77_20 Full Text | PDF [698]
|